{"input_url":"https://www.pharmexec.com/view/fda-votes-loosen-restrictions-four-peptides","gnews_decode":"https://www.pharmexec.com/view/fda-votes-loosen-restrictions-four-peptides","http_status":200,"final_url":"https://www.pharmexec.com/view/fda-votes-loosen-restrictions-four-peptides","html_length":451379,"trafilatura_result":"ok","text_length":6367,"text_preview":"\"I'm voting on something here, but I don't know what that something is. It's kind of like a black box to me.\"\nFDA Panel Votes to Loosen Restrictions for Four Peptides\nKey Takeaways\n- Narrow votes supported compounding of BPC-157, KPV, and TB-500 (8-6; one abstention) and MOTS-c (7-5; two abstentions","verdict":"OK"}